Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs, 1-1/2 months after a federal judge ...

("XTM" or the "Company") (CSE:PAID / FSE:7XT) a Miami, Toronto, and London-based Fintech creator of innovative payment solutions including tip-payout and certified Earned Wage Access (EWA) through its ...